Rever3mab (Takis)

N/A

Report date: 2026/04/08 20:02:35

Base Information

Drug NameRever3mab (Takis)

Drug Alias NameTel-eVaxTK-003

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccineCell and gene therapy > Gene therapy > Plasmid

Mechanisms of ActionTelomerase reverse transcriptase inhibitors

TargetsTelomerase reverse transcriptase

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItaly

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTakis

China Registration ClassN/A

Develop Information

Active CompaniesTakis

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A